Clark & Stuart Inc’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$634K Buy
8,027
+1,700
+27% +$137K 0.4% 37
2026
Q1
$553K Buy
6,327
+500
+9% +$47.9K 0.37% 36
2025
Q4
$564K Sell
5,827
-500
-8% -$48.6K 0.39% 35
2025
Q3
$607K Hold
6,327
0.43% 34
2025
Q2
$556K Hold
6,327
0.42% 33
2025
Q1
$573K Hold
6,327
0.42% 32
2024
Q4
$509K Buy
+6,327
New +$548K 0.37% 33

Other funds holding MDT

Clark & Stuart Inc's MDT Position: Q2 2026 in Review

Clark & Stuart Inc increased its Medtronic (MDT) stake by 27% in Q2 2026, buying an estimated $137K and bringing the position to 8,027 shares worth $634K. The position accounts for 0.4% of the portfolio, ranked #37.

Clark & Stuart Inc first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. 535 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Clark & Stuart Inc held 8,027 shares of Medtronic worth $634K as of Q2 2026.
  • Clark & Stuart Inc bought 1,700 Medtronic shares in Q2 2026, an estimated $137K.
  • Medtronic made up 0.4% of Clark & Stuart Inc's portfolio in Q2 2026, its #37 holding.
  • Clark & Stuart Inc first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • 535 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Clark & Stuart Inc's 13F filing for Q2 2026, filed 14 Jul 2026.